tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

KALA Stock Latest News

Kala Pharmaceuticals Faces Default Notice from Oxford Finance
Company AnnouncementsKala Pharmaceuticals Faces Default Notice from Oxford Finance
19d ago
8K
KALA
Kala Bio downgraded to Neutral from Outperform at Mizuho
PremiumThe Fly
Kala Bio downgraded to Neutral from Outperform at Mizuho
20d ago
KALA
Kala Bio downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe Fly
Kala Bio downgraded to Neutral from Buy at H.C. Wainwright
21d ago
KALA
H.C. Wainwright downgrades Kala Bio to Neutral after CHASE trial miss
PremiumThe Fly
H.C. Wainwright downgrades Kala Bio to Neutral after CHASE trial miss
21d ago
KALA
Kala Bio shared no details on study miss, says Mizuho
PremiumThe Fly
Kala Bio shared no details on study miss, says Mizuho
21d ago
KALA
Kala Pharmaceuticals downgraded to Market Perform at LifeSci Capital
PremiumThe FlyKala Pharmaceuticals downgraded to Market Perform at LifeSci Capital
21d ago
KALA
Kala Pharmaceuticals trading resumes
Premium
The Fly
Kala Pharmaceuticals trading resumes
21d ago
KALA
Kala Pharmaceuticals trading halted, volatility trading pause
Premium
The Fly
Kala Pharmaceuticals trading halted, volatility trading pause
21d ago
KALA
Kala Pharmaceuticals Halts KPI-012 Development After Trial Failure
PremiumCompany Announcements
Kala Pharmaceuticals Halts KPI-012 Development After Trial Failure
21d ago
8K
KALA
Kala to cease development of KPI-012, evaluate strategic options
PremiumThe Fly
Kala to cease development of KPI-012, evaluate strategic options
21d ago
KALA
Kala says CHASE Phase 2b KPI-012 trial did not meet primary endpoint
PremiumThe Fly
Kala says CHASE Phase 2b KPI-012 trial did not meet primary endpoint
21d ago
KALA
Kala Pharmaceuticals Sets Date for Annual Meeting
PremiumCompany Announcements
Kala Pharmaceuticals Sets Date for Annual Meeting
1M ago
8K
KALA
Strategic Positioning and Trial Design Propel Kala Pharmaceuticals to ‘Buy’ Rating
PremiumRatingsStrategic Positioning and Trial Design Propel Kala Pharmaceuticals to ‘Buy’ Rating
1M ago
KALA
Kala Pharmaceuticals price target raised to $35 from $12 at H.C. Wainwright
Premium
The Fly
Kala Pharmaceuticals price target raised to $35 from $12 at H.C. Wainwright
1M ago
KALA
Kala Pharmaceuticals price target raised to $33 from $15 at Oppenheimer
Premium
The Fly
Kala Pharmaceuticals price target raised to $33 from $15 at Oppenheimer
1M ago
KALA
Kala Pharmaceuticals initiated with an Outperform at Mizuho
PremiumThe Fly
Kala Pharmaceuticals initiated with an Outperform at Mizuho
1M ago
KALA
Kala Pharmaceuticals management to meet with Piper Sandler
PremiumThe Fly
Kala Pharmaceuticals management to meet with Piper Sandler
2M ago
KALA
Kala Pharmaceuticals initiated with an Outperform at LifeSci Capital
PremiumThe Fly
Kala Pharmaceuticals initiated with an Outperform at LifeSci Capital
2M ago
KALA
Kala Pharmaceuticals Appoints Todd Bazemore as CEO
PremiumCompany Announcements
Kala Pharmaceuticals Appoints Todd Bazemore as CEO
2M ago
8K
KALA
Kala Bio appoints Bazemore as President, CEO, Director
PremiumThe FlyKala Bio appoints Bazemore as President, CEO, Director
2M ago
KALA
Optimistic Buy Rating for Kala Pharmaceuticals Driven by KPI-012 Trial Prospects and Financial Viability
Premium
Ratings
Optimistic Buy Rating for Kala Pharmaceuticals Driven by KPI-012 Trial Prospects and Financial Viability
2M ago
KALA
Kala Pharmaceuticals Reports Q2 2025 Financial Results
Premium
Company Announcements
Kala Pharmaceuticals Reports Q2 2025 Financial Results
2M ago
KALA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >